Fairmount Funds Management LLC Diversified Active

Location: West Conshohocken, PA

CIK: 0001802528 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $1.314B (100.0% shares, 0.0% debt)

Holdings (13)

COGT COGENT BIOSCIENCES INC 24.3%

Value $320M Shares 9,003,418 Est. Cost $9.55 Unrealized +194.3%

APGE APOGEE THERAPEUTICS INC 11.8%

Value $155M Shares 2,048,647 Est. Cost $22.03 Unrealized +185.9%

SYRE SPYRE THERAPEUTICS INC 10.0%

Value $132M Shares 4,018,101 Est. Cost $31.80 Unrealized -17.8%

VRDN VIRIDIAN THERAPEUTICS INC 9.3%

Value $122M Shares 3,914,458 Est. Cost $17.81 Unrealized +54.0%

ORKA ORUKA THERAPEUTICS INC 8.5%

Value $112M Shares 3,705,262 Est. Cost $32.55 Unrealized -14.4%

DNTH DIANTHUS THERAPEUTICS INC 6.7%

Value $88.07M Shares 2,137,191 Est. Cost $17.22 Unrealized +125.2%

ZBIO ZENAS BIOPHARMA INC 6.1%

Value $80.21M Shares 2,209,025 Est. Cost $20.11 Unrealized +63.5%

NUVL NUVALENT INC 5.6%

Value $73.19M Shares 727,563 Est. Cost $22.67 Unrealized +335.0%

JBIO JADE BIOSCIENCES INC 5.3%

Value $70.26M Shares 4,553,494 Est. Cost $26.99 Unrealized -56.5%

ELVN ENLIVEN THERAPEUTICS INC 4.4%

Value $57.16M Shares 3,711,444 Est. Cost $18.70 Unrealized +6.5%

KNSA KINIKSA PHARMACEUTICALS INTL 4.1%

Value $54.44M Shares 1,319,688 Est. Cost $21.28 Unrealized +88.5%

CBIO CRESCENT BIOPHARMA INC. 2.5%

Value $32.59M Shares 2,747,866 Est. Cost $16.99 Unrealized -25.0%

IKT INHIBIKASE THERAPEUTICS INC 1.3%

Value $17.68M Shares 8,625,000 Est. Cost $2.23 Unrealized -28.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
COGT	COGENT BIOSCIENCES INC	9,003,418	$320M	24.3%	$9.55	+194.3%	COM	19240Q201
APGE	APOGEE THERAPEUTICS INC	2,048,647	$155M	11.8%	$22.03	+185.9%	COM	03770N101
SYRE	SPYRE THERAPEUTICS INC	4,018,101	$132M	10.0%	$31.80	-17.8%	COM NEW	00773J202
VRDN	VIRIDIAN THERAPEUTICS INC	3,914,458	$122M	9.3%	$17.81	+54.0%	COM	92790C104
ORKA	ORUKA THERAPEUTICS INC	3,705,262	$112M	8.5%	$32.55	-14.4%	COM	687604108
DNTH	DIANTHUS THERAPEUTICS INC	2,137,191	$88.07M	6.7%	$17.22	+125.2%	COM	252828108
ZBIO	ZENAS BIOPHARMA INC	2,209,025	$80.21M	6.1%	$20.11	+63.5%	COM	98937L105
NUVL	NUVALENT INC	727,563	$73.19M	5.6%	$22.67	+335.0%	COM	670703107
JBIO	JADE BIOSCIENCES INC	4,553,494	$70.26M	5.3%	$26.99	-56.5%	COM NEW	008064206
ELVN	ENLIVEN THERAPEUTICS INC	3,711,444	$57.16M	4.4%	$18.70	+6.5%	COM	29337E102
KNSA	KINIKSA PHARMACEUTICALS INTL	1,319,688	$54.44M	4.1%	$21.28	+88.5%	ORD SHS CL A	G52694109
CBIO	CRESCENT BIOPHARMA INC.	2,747,866	$32.59M	2.5%	$16.99	-25.0%	COM	G2545C104
IKT	INHIBIKASE THERAPEUTICS INC	8,625,000	$17.68M	1.3%	$2.23	-28.7%	COM NEW	45719W205